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Excessive uptake of oxidized low-density lipopro-
teins (oxLDL) by macrophages is a fundamental
characteristic of atherosclerosis. However, signals
regulating the engagement of these ligands remain
elusive. Using single-molecule imaging, we discov-
ered a mechanism whereby chemokine signaling
enhanced binding of oxLDL to the scavenger re-
ceptor, CD36. By activating the Rap1-GTPase, che-
mokines promoted integrin-mediated adhesion of
macrophages to the substratum. As a result, cells
exhibited pronounced remodeling of the cortical
actin cytoskeleton that increased CD36 clustering.
Remarkably, CD36 clusters formed predominantly
within actin-poor regions of the cortex, and these re-
gions were primed to engage oxLDL. In accordance
with enhanced ligand engagement, prolonged ex-
posure of macrophages to chemokines amplified
the accumulation of esterified cholesterol, thereby
accentuating the foam cell phenotype. These find-
ings imply that the activation of integrins by chemo-
kine signaling exerts feedforward control over recep-
tor clustering and effectively alters the threshold for
cells to engage ligands.INTRODUCTION
Sterile inflammation is an inherent feature of atherosclerosis initi-
ated by the accumulation of modified lipoproteins beneath the
vascular wall. Among the reported modifications, oxidation of
low-density lipoproteins is thought to be the most significant,
promoting endothelial cell dysfunction and the recruitment of
monocyte-derived macrophages to the vessel intima (Tabas
et al., 2007; Williams and Tabas, 1999). While the internalizationCellof oxLDL by recruited macrophages is initially deemed benefi-
cial, excessive consumption results in the formation of choles-
terol-rich foam cells, which, in turn, succumb to necrosis, release
pro-inflammatory stimuli, and ultimately perpetuate a non-
resolving, sterile inflammatory response (Seimon et al., 2010;
Sheedy et al., 2013; Stewart et al., 2010). Why macrophages
continually engulf oxLDL to their own detriment and to that of
the surrounding microenvironment remains poorly understood.
In both human andmurinemacrophages, the engagement and
internalization of oxLDL is primarily mediated by the class B
scavenger receptor CD36 (Endemann et al., 1993; Febbraio
et al., 2000; Kunjathoor et al., 2002; Nozaki et al., 1995). While
many receptors are commonly assumed to exist as monomers
in the plasma membrane, CD36 exists as multimers, which are
metastable in the absence of ligand (Jaqaman et al., 2011).
The pre-clustering of CD36 may prime macrophages to engage
oxLDL, which is multivalent and can simultaneously engagemul-
tiple receptors (Jaqaman et al., 2011).
The ability of receptors to cluster is dictated by their lateral
diffusion within the plane of the plasma membrane. However, it
has become increasingly apparent thatmany barriers to diffusion
exist, effectively limiting the extent of receptor clustering. In this
regard, bulky transmembrane proteins can serve as molecular
pickets anchored to underlying compartment boundaries, which
are structured by the cortical actin cytoskeleton and impede the
diffusion of mobile membrane proteins (Kusumi et al., 2005). To
date, signals that modulate CD36 diffusion and clustering, and
the resulting impact on the internalization of oxLDL, remain
elusive.
During an inflammatory event,macrophages integratemultiple
signals, generating context-dependent responses (Bezbradica
et al., 2014; Freeman and Grinstein, 2014). Indeed, numerous
studies using genetically modified mice suggest that the clear-
ance of oxLDL during atherogenesis is a tunable process modu-
lated by the cytokine milieu (Kleemann et al., 2008). Chemokines
are among the initial cytokines encountered by a macrophage,
guiding a continued influx of cells to the intima, and their effects
persist throughout vascular inflammation. Although chemokinesReports 14, 2859–2871, March 29, 2016 ª2016 The Authors 2859
are traditionally known for their role in orchestrating cell migra-
tion, they can influence immune cell function by several addi-
tional mechanisms (Zernecke and Weber, 2014). For instance,
CX3CL1, also known as fractalkine, serves as an anti-apoptotic,
pro-survival signal for monocytes and macrophages (Landsman
et al., 2009), while CXCL12 enhancesmacrophage phagocytosis
of unopsonized E. coli aswell as acetylated LDL (Ma et al., 2013).
Activation of the Rap1 GTPase, which is a common signaling
node triggered downstream of chemokine G protein-coupled re-
ceptors (GPCRs), can also enhance the phagocytic activity of
macrophages toward certain ligands (Caron et al., 2000; Kim
et al., 2012).
Given the accumulating evidence describing the function of
chemokines beyond cell migration, and the significant contribu-
tion of chemokines to vascular disease (Zernecke and Weber,
2010), we investigated whether they could contribute to athero-
genesis through additional mechanisms. Initially, we focused on
the chemokine CX3CL1, and later, generalized our findings to
CCL2 and CXCL12. Our results demonstrate that by enhancing
integrin activation and signaling, chemokines regulate the state
of the cortical actin cytoskeleton, which in turn determines the
extent of CD36 clustering. This mechanism controls the ability
of macrophages to engage oxLDL and contributes to the forma-
tion of foam cells. These data suggest that modulation of recep-
tor clustering by cytokines may serve as a generalized mecha-
nism for fine-tuning ligand engagement and the progression of
inflammation.
RESULTS
CX3CL1 Signaling Enhances the Uptake of Oxidized
Lipoproteins through CD36
We hypothesized that in addition to promoting migration and
survival of monocytes/macrophages, CX3CL1 could directly
impact the uptake of oxLDL. To test this notion, oxLDL internal-
ization was assessed in bone-marrow-derived macrophages
(BMDMs) isolated from wild-type (WT) or CD36-deficient mice
(Figures 1A and 1B). Following incubation with oxLDL and prior
to fixation, cells were incubated briefly with trypsin, which
cleaved exofacial receptor-ligand complexes, ensuring that
only internalized oxLDL was quantified. As previously reported
(Febbraio et al., 2000), CD36-deficient cells internalized approx-
imately 60% less oxLDL when compared to WT counterparts
(Figures 1A and 1B). The specificity of the oxLDL for CD36 was
also confirmed through heterologous expression of CD36-GFP
in HeLa cells (Figure S1A). When compared to non-transfected
controls within the same field of view, CD36-GFP expressing
cells bound 2.24-fold more oxLDL but bound a comparable
amount of native LDL (Figures S1B and S1C). Interestingly,
CD36-expressing cells also bound slightly more acetylated
LDL compared to non-transfected controls (Figure S1C). In the
presence of CX3CL1, WT macrophages internalized 1.71-fold
more oxLDL, an effect that was not observed in CD36-deficient
cells (Figures 1A and 1B, p < 0.05 and p < 0.0001, respectively).
Similar results were also observed in culturedmurine RAW 264.7
macrophages using CD36 blocking antibodies (Figures S2A and
S2B). These observations did not stem from global increases in
endocytosis, as the uptake of transferrin, which occurs through2860 Cell Reports 14, 2859–2871, March 29, 2016 ª2016 The Authorclathrin-mediated endocytosis, was unaffected by CX3CL1
(Figure S2C).
Enhanced internalization of oxLDL could result from increased
receptor-ligand engagement. This possibility was investigated
by incubating macrophages with oxLDL for 1 min. A brief expo-
sure to trypsin cleaved >95% of receptor-ligand complexes,
confirming that surface-bound rather than internalized oxLDL
were being visualized (data not shown). As illustrated in Figures
1C and S2D, pre-incubation of BMDMs or RAW 264.7 macro-
phages with CX3CL1 enhanced binding of oxLDL by 2.18- and
2.67-fold, respectively (Figures 1C and 1D, p < 0.05 versus con-
trol). These results were not due to non-specific effects of pro-
tein, or due to LPS contamination as macrophages deficient in
the CX3CL1 receptor, CX3CR1, did not exhibit enhanced binding
of oxLDL when exposed to the chemokine (Figure 1D). Further-
more, the increased binding was not due to enhanced surface
expression of CD36 (Figure 1E). These data suggest that
CX3CL1 enhances the initial binding of oxLDL, likely by altering
the kinetics of CD36-oxLDL interactions.
CX3CL1 Increases the Lateral Diffusion and Clustering
of CD36
CD36 was recently described to form metastable multimers in
the absence of ligand (Jaqaman et al., 2011). Such pre-clustering
may prime the cells for the engagement of multivalent ligand, by
increasing the avidity of its interaction with receptors. Therefore,
it was conceivable that exposing macrophages to CX3CL1might
alter CD36 clustering and hence its ability to bind oxLDL. To
assess this possibility, we imaged single receptors on the dorsal
surface of human monocyte-derived macrophages (HMDMs)
using anti-CD36 Fab fragments followed by secondary, Cy3-
conjugated Fab fragments as previously described (Jaqaman
et al., 2011). Since individual Cy3 fluorophores have defined fluo-
rescence intensity, CD36 clustering was estimated based on the
intensity of each feature. Of note, we determined thatz85% of
the secondary Fab fragments were conjugated to a single Cy3
(Figures S3A and S3B).
We proceeded to perform modal analysis of CD36 intensity
histograms using the highest labeling density of Fab fragments
that allowed us to resolve single features (Figure 2A). As previ-
ously described, multiple intensity modes were found in resting
macrophages, confirming that CD36 exists asmultimers (Figures
2A and 2C) (Jaqaman et al., 2011). Importantly, individual fea-
tures photobleached in a stepwise fashion with a step size
similar to both the mean of the first mode in the intensity histo-
gram, and the intensity of a single Cy3 fluorophore, validating
our ability to detect single molecules (Figures 2A and S3A–
S3D). Following exposure to CX3CL1, the fraction of CD36
features corresponding to one Cy3 fab fragment decreased
from 0.72 ± 0.03 to 0.61 ± 0.02, while the fraction corresponding
to two Cy3 increased from 0.24 ± 0.02 to 0.31 ± 0.02, and the
fraction corresponding to three or more Cy3 increased from
0.04 ± 0.01 to 0.08 ± 0.01 (mean ± SEM, p < 0.05 for all compar-
isons, Figures 2A–2C). These results imply that CX3CL1 in-
creases CD36 clustering.
Increased CD36 clustering could be the result of increased
lateral diffusion and subsequent receptor coalescence within
the plane of the plasma membrane. To test this notion, wes
Figure 1. CX3CL1 Increases CD36-Mediated Uptake of oxLDL
(A) Internalization of DiI oxLDL (red) was assessed for 20 min in WT or CD36/ BMDMs treated with or without CX3CL1. WGA-488 (green) was used to visualize
the plasma membrane of individual cells. Representative extended focus projections obtained using spinning-disk confocal microscopy.
(B) Quantification of (A). The integrated fluorescence of DiI oxLDL was measured per cell (see Experimental Procedures). Data are from three independent
experiments with BMDMs from three different mice. For each condition, 20–40 cells were quantified per experiment. Boxplots represent the pooled distribution of
single cells, illustrating themedian (central line), interquartile ranges (lower and upper regions of the box), inlier data points (gray dotted whiskers), and outlier data
points (gray crosses).
(C) DiI oxLDL binding was assessed for 1 min in WT or CX3CR1
/ BMDMs. Representative XY optical slices of WT BMDMs were obtained using spinning-disk
confocal microscopy.
(D) Quantification of (C). DiI oxLDL fluorescence was quantified per cell as in (B). Data are from three independent experiments performed in BMDMs from two
different mice. For each condition, 25–30 cells were quantified per experiment. Boxplots are as in (B).
(E) Surface expression of CD36 control or CX3CL1-treated RAW 264.7 macrophages assessed by flow cytometry. Representative histogram illustrating the
fluorescence distribution of single cells (n = 3).
For (A) and (C), scale bars, 10 mm. For (B) and (D), *p < 0.05, ***p < 0.0001 were determined by the Kruskal-Wallis test using Dunn’smultiple comparisons test. See
also Figure S1.performed single-molecule tracking of CD36 using quantum dots
(Qdots) as described by Jaqaman et al. (2008, 2011) (see Exper-
imental Procedures). Previously, CD36 diffusion was classified
using two approaches. First, individual trajectories were charac-
terized as linear or isotropic. Second, these same trajectories
were subjected to moment scaling spectrum (MSS) analysis,
which classifies motion as either confined (subdiffusive) or free
(Jaqaman et al., 2008, 2011).While all components of the analysis
are documented in Figure S3E, for simplicity the results hereafter
are classified as confined and freemotion, irrespective of linearity.
As shown in Figures 2D and 2E, exposing macrophages to
CX3CL1 enhanced the diffusion of CD36, decreasing confined
motion from59%± 3%to41%± 2%,while increasing freemotion
from 41% ± 3% to 59% ± 2% (mean ± SEM, p < 0.0001 for
each comparison). The overall diffusion coefficient of CD36 also
increased from 0.024 ± 0.002 mm2/s to 0.035 ± 0.002 mm2/sCell(mean ± SEM, p < 0.05, Figure 2F). Taken together, these re-
sults suggest that CX3CL1 increases the ability of CD36 to form
transient clusters by increasing the lateral diffusion of the
receptor.
CX3CL1 Dynamizes the Actin Cytoskeleton, Creating
Zones that Facilitate CD36 Clustering
The lateral diffusion and clustering of CD36, as well as other im-
munoreceptors, is governed in part by the cortical actin cytoskel-
eton (Andrews et al., 2008; Freeman et al., 2015; Jaqaman et al.,
2011; Jaumouille´ et al., 2014). Because CX3CL1 was reported to
alter actin cytoskeletal dynamics in macrophages (Gevrey et al.,
2005; Park and Cox, 2011), we considered whether it increased
CD36 clustering and diffusion by remodeling the cytoskeleton.
Similar to previous studies (Gevrey et al., 2005), CX3CL1 induced
the formation of actin-driven ruffles (Figure 3A). In addition toReports 14, 2859–2871, March 29, 2016 ª2016 The Authors 2861
Figure 2. CX3CL1 Increases the Lateral Diffusion and Clustering of CD36
(A and B) Control (A) and CX3CL1-treated (B) HMDMs. Representative fluorescence intensity histogram of cell-surface CD36 molecules detected using Cy3-
conjugated Fabs decomposed into individual intensity modes (dotted blue lines, individual modes; solid gray lines, sum of all modes). Arrows indicate eachmode
center; numbers represent the fluorescence intensity of each mode center.
(C) CD36 clustering determined using the modal analysis in (A) and (B). Data are from three independent experiments, each with eight to 15 cells per condition.
(D) Single-molecule tracking of cell-surface CD36 in control or CX3CL1-treated HMDMs. CD36 molecules were detected using Qdots and recorded at 33 Hz for
10 s. Motion was determined using MSS analysis. Representative CD36 trajectories are shown (blue, confined motion; cyan, free motion). Scale bars, 4 mm.
(E) Fraction of CD36 molecules undergoing confined and free motion with and without CX3CL1. ***p < 0.0001 was determined by unpaired, two-tailed t test.
(F) Median diffusion coefficients for all particles (irrespective of motion type) with and without CX3CL1.
*p < 0.05 was determined by unpaired, two-tailed t test. For (E) and (F), individual dots correspond to single cells pooled from three independent experiments,
each with eight to 12 cells. Horizontal lines represent the means of the pooled data. See also Figure S2.ruffling, two additional phenomena were observed. First, com-
pared to resting macrophages, CX3CL1 significantly reduced
the amount of cortical F-actin at the dorsal cell surface, resulting
in a decrease in the dorsal to ventral F-actin ratio (Figures 3B
and 3C). Of note, the decrease in dorsal F-actin coincided
with the appearance of podosome structures on the ventral
surface (Figure 3B). Second, exposure to CX3CL1 introduced
pronounced heterogeneity in the distribution of dorsal cortical
F-actin, promoting the appearance of actin-poor regions adja-
cent to actin-rich ruffles (Figures 3B and 3D). This was in sharp
contrast to resting macrophages, which exhibited relatively
thick, homogenous cortical F-actin at the dorsal surface (Figures
3B and 3C). Despite these effects on cytoskeletal rearrange-
ment, CX3CL1 did not alter the total F-actin content per cell
(Figure 3E).
Ruffling is thought to be critical for the capture of immunoglob-
ulin G (IgG)-opsonized targets by innate immune cells (Flanna-2862 Cell Reports 14, 2859–2871, March 29, 2016 ª2016 The Authorgan et al., 2010). It is therefore conceivable that ruffles also aid
in the capture of oxLDL. This hypothesis was initially investigated
by immunostaining for CD36, followed by structured illumination
microscopy (SIM), which enabled us to assess the distribution
of the receptor with respect to the ruffles beyond the resolution
of conventional, diffraction-limited microscopy. Remarkably,
CD36 clusters were predominantly excluded from F-actin ruffles,
residing instead in adjacent F-actin-poor zones of the cortex
(Figures 3F, 3G, S4A, and S4C). Furthermore, clusters of CD36
in actin-poor zones were 2.6 ± 0.4-fold larger than those in
actin-rich regions (Figure 3G; mean ± SEM, p < 0.001). By
contrast, FcgIIa receptors, which bind IgG opsonized targets,
were found homogenously distributed throughout ruffles and
the dorsal cortex (Figure S4B), suggesting that the uneven distri-
bution of CD36 was not an artifact of the SIM deconvolution pro-
cess. Most importantly, larger oxLDL particles preferentially
bound to the F-actin-depleted zones in which CD36 clusterss
Figure 3. CX3CL1 Dynamizes the Actin Cytoskeleton, Creating Zones that Facilitate CD36 Clustering
(A) Representative DIC stills from a time-lapsed video of the same HMDM before and after treatment with CX3CL1. Arrows highlight peripheral and dorsal ruffles.
(B) F-actin distribution in HMDMs with and without CX3CL1 visualized with phalloidin-488. Representative extended focus z projections (top) and corresponding
XZ optical slices (bottom) obtained using spinning-disk confocal microscopy. Arrows highlight ruffles and asterisks highlight adjacent, F-actin poor regions.
(C) Quantification of the dorsal to ventral F-actin ratio per cell based on phalloidin-488 fluorescence intensity. ***p < 0.0001 was determined by the Kolmogorov-
Smirnov test.
(D) Quantification of the F-actin poor regions per cell as a percentage of total surface area based on phalloidin-488 fluorescence intensity. ***p < 0.0001 was
determined by the Kolmogorov-Smirnov test.
(E) Quantification of total F-actin based on the integrated phalloidin-488 intensity per cell. For (C)–(E), data are from three independent experiments, each with ten
to 20 cells. Boxplots are as in Figure 1.
(F) Cell-surface CD36 (top panel, clone MF3) and Alexa-647-conjugted oxLDL (bottom panel) distribution was assessed with respect to F-actin in BMDMs.
Representative XY optical slices obtained using SIM. Scale bars, 1 mm.
(G andH)Quantification of (F). Distribution of CD36 cluster size and oxLDL particle size within actin-rich and actin-poor regionsmeasured throughout an entire cell
in 3D. Each dot corresponds to an individual CD36 cluster or oxLDL from a single, representative cell. Red lines represent median particle size. Three independent
experiments were performed, each with five cells. ***p < 0.0001 was determined by the Kolmogorov-Smirnov test.
(I) DiI oxLDL binding was performed as in Figure 1C in BMDMs derived fromWT or Rac1-deficient (Rac 1/) mice. Data are from three independent experiments,
eachwith 28–40 cells, and are normalized to theWT control. Boxplots are as in Figure 1. *p < 0.05 was determined by the Kruskal-Wallis test using Dunn’smultiple
comparisons test.
(J) HMDMs expressing a generic plasma membrane marker (PM-GFP) or constitutively active Rac1 (RacQ61L-GFP). Quantification of oxLDL binding was
performed as in (G).
Data are from three independent experiments, each with eight to 12 cells. Boxplots are as in (C)–(E) and (G). **p < 0.01 was determined by the Kolmogorov-
Smirnov test. See also Figure S3.
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resided (Figures 3F, 3H, and S4D). It should be noted that uncon-
trolled disruption of F-actin was not sufficient to increase binding
of oxLDL as exposing macrophages to a low concentration
of latrunculin B (500 nM for 4 min) increased CD36 diffusion,
yet had little effect on oxLDL engagement (Figures S3F and
S3G; data not shown). Therefore, a dynamic balance between
ruffling and the creation of zones poor in F-actin is required to
enhance oxLDL binding. Collectively, these data suggest that
CX3CL1 creates actin-poor zones that promote CD36 receptor
coalescence.
We proceeded to confirm that CX3CL1-induced cytoskeletal
remodeling was required for enhanced oxLDL binding. Initially,
BMDMs were isolated from either WT mice, or mice deficient
in Rac1 (Rac1/), a critical mediator of cytoskeletal dynamics
that has previously been implicated in CX3CL1-induced ruffling,
as well as cytokine-induced ruffling in general (Park and Cox,
2011; Ridley et al., 1992; Wells et al., 2004). In response to
CX3CL1, WT macrophages bound twice as much oxLDL
compared to untreated controls (p < 0.05 versus WT control)
(Figure 3I). However, this effect was not observed in the Rac1/
macrophages (p < 0.05). These results were verified by transfect-
ing HMDMs with a plasmid encoding a constitutively active form
of Rac1 (Rac1Q61L-GFP), generating a dynamic actin cortex
comprising oversized ruffles and adjacent F-actin-poor zones
(Figures S4E and S4F). Expression of Rac1Q61L-GFP increased
binding of oxLDL by 1.93-fold compared to cells expressing a
generic plasma membrane marker (PM-GFP) as a control (p <
0.001) (Figure 3J). Therefore, the effects of CX3CL1 on oxLDL
engagement are mediated by cytoskeletal remodeling.
CX3CL1 Increases oxLDLBinding byActivating Integrins
We next questioned the mechanism by which CX3CL1 altered
the cytoskeleton. In macrophages, integrin-mediated adhesion
and subsequent outside-in signaling can dictate the organization
of the actin cytoskeleton, in part by regulating Rho GTPases
such as Rac1 (Abram and Lowell, 2009; del Pozo et al., 2004;
Jaumouille´ et al., 2014; Okigaki et al., 2003). Since CX3CL1
caused a significant increase in the appearance of podosomes
(Figures 3B and 4A), which are integrin-rich structures implicated
in cell adhesion, and because many chemokines have been re-
ported to promote integrin activation (Abram and Lowell, 2009;
Murphy and Courtneidge, 2011), we tested whether integrin-
mediated adhesion influenced oxLDL binding. To this end, we
employed specific b1 and b2 integrin blocking antibodies and
found that they significantly limited CX3CL1-induced actin re-
sponses and the binding of oxLDL (Figures 4B and 4C). EDTA
was next used to inhibit integrins and lift macrophages into
suspension. Following the removal of EDTA by washing, cells
were re-suspended in medium containing calcium, incubated
with chemokine, and assessed for their ability to engage oxLDL.
As shown in Figure 4D, exposing suspended macrophages
to CX3CL1 had little effect on the engagement of oxLDL. There-
fore, CX3CL1 enhances oxLDL binding in adherent cells only,
seemingly by remodeling the cytoskeleton following integrin
engagement.
We proceeded to confirm that CX3CL1 in fact promoted integ-
rin-mediated adhesion. Initially, cell spreading on integrin li-
gands was assessed. HMDMs were lifted into suspension and2864 Cell Reports 14, 2859–2871, March 29, 2016 ª2016 The Authorre-plated onto the integrin ligand, fibronectin, revealing that
CX3CL1 increased the spreading area of cells from 510 mm
2 (in-
terquartile range [IQR] = 219–949 mm2) to 1116 mm2 (IQR =
783.6–2180 mm2) (p < 0.0001) (Figure 4E). Furthermore,
CX3CL1 doubled the number of adherent cells per field of view
(Figure S5A). Increased adhesion could be the result of inside-
out integrin activation, which involves activation of the Rap1
GTPase. (Abram and Lowell, 2009). Consistent with this notion,
we found that CX3CL1 increased the amount of active Rap1
(Rap1-GTP) in macrophages by 74% (p < 0.0001) compared to
untreated controls (Figure 4F). Additionally, treatment with
CX3CL1 significantly increased binding of the MEM-148 mono-
clonal antibody, which recognizes the high affinity, b2 integrin
conformation (Figure S5B).
The role of Rap1 in oxLDL binding was next probed by trans-
fecting RAW264.7macrophages with a plasmid encoding Rap1-
GapII, which hydrolyzes active Rap1-GTP to the inactive form,
Rap1-GDP. As illustrated in Figures 4G and 4H, cells expressing
Rap1GapII did not respond to CX3CL1 (p < 0.0001) compared to
untransfected controls in the same field of view, and even bound
less oxLDL under basal conditions (p < 0.05). Conversely, ex-
pressing a constitutively active form of Rap1 (Rap1V12)
enhanced binding of oxLDL 1.7-fold (IQR = 1.35–2.20) (p <
0.0001 versus control) (Figure 4I).
Following inside-out activation, integrins more readily engage
their ligands, such as extracellular matrix (ECM) proteins, and
transduce outside-in signals that alter actin cytoskeletal archi-
tecture. These signals can remodel actin both locally and
remotely, likely accounting for the effect of CX3CL1 on CD36
clustering and oxLDL binding at the dorsal cell surface. In order
to transmit most outside-in signals, integrinsmust anchor the un-
derlying actin cytoskeleton through linkers such as talin and vin-
culin (Abram and Lowell, 2009). While macrophages transfected
with WT talin (TalinWT-GFP) responded normally to CX3CL1 and
bound more oxLDL, those transfected with TalinHD, which
serves as a dominant negative for the endogenous protein, did
not (p < 0.0001 versus Talin-WT + CX3CL1, Figures 4J and 4K).
In fact, cells expressing TalinHD bound 40% less oxLDL
even under basal conditions when compared to cells expressing
TalinWT (p < 0.05; Figure 4K). Taken together, these observa-
tions are most consistent with a model whereby CX3CL1 acti-
vates the Rap1 GTPase and promotes integrin-mediated adhe-
sion. The resulting outside-in integrin signals then act at
remote sites of the cell, remodeling cortical actin at the dorsal
surface, which, in turn, increases CD36 clustering and subse-
quent binding of oxLDL.
CD36 Clustering Is Regulated by Chemokine Signaling
The conserved activation of the Rap1 GTPase and integrins
downstream of chemokine GPCRs suggests that the effect of
CX3CL1 on CD36 clustering may be a generalized phenomenon
induced by numerous chemokines. To explore this possibility,
we selected two additional, structurally distinct chemokines
that can activate Rap1 and assessed their effects on CD36 clus-
tering and oxLDL binding (Katagiri et al., 2003; Yi et al., 2012).
Among the possible candidates, we chose CCL2, which has pre-
viously been implicated in potentiating the severity of atheroscle-
rosis, and CXCL12, which has been implicated in promotings
Figure 4. CX3CL1 Increases oxLDL Binding by Activating Integrins
(A) Quantification of the percentage of HMDMs with visible podosomes assessed by phalloidin-488 staining. Data are mean ± SEM from three independent
experiments, each with 15–30 cells quantified. **p < 0.001 was determined by unpaired two-tailed t test.
(B) HMDMswere pre-incubated with an isotype control, or b1 and b2 integrin blocking Abs before being exposed to CX3CL1. Quantification of the dorsal to ventral
F-actin ratio as in Figure 3C.
(C) HMDMs treated as in (B). Binding of DiI oxLDL was assessed as in Figure 1C. For (B) and (C), data are from three independent experiments, each with ten to 20
cells quantified. Boxplots are as in Figure 1B. *p < 0.05, ***p < 0.0001 were determined by the Kruskal-Wallis test using Dunn’s multiple comparisons test.
(D) Binding of Alexa-647-conjugted oxLDL to RAW 264.7 macrophages in suspension pre-treated with or without CX3CL1. Representative histogram demon-
strating the fluorescence distribution of single cells obtained using flow cytometry (n = 3).
(E) HMDMswere laid onto fibronectin-coated substrates for 10min. Quantification of the spreading area in cells pre-treatedwith or without CX3CL1. ***p < 0.0001
was determined by the Kolmogorov-Smirnov test.
(F) Quantification of Rap1-GTP in RAW264.7macrophages treatedwith CX3CL1 (1min) by biochemical pull-down using RalGDS-GST. Ratio of Rap1-GTP to total
Rap1 was normalized to control conditions. Representative immunoblot (top panel). Data are mean ± SEM from three independent experiments. ***p < 0.0001
was determined by unpaired two-tailed t test.
(G) RAW 264.7 macrophages expressing Rap1GAPII-RFP. Alexa-647-conjugated oxLDL binding was assessed as in Figure 1C. Representative XY optical slices
of CX3CL1-treated macrophages obtained using spinning-disk confocal microscopy. Scale bar, 10 mm.
(H) Quantification of (E) as in Figure 1D. Only transfected and non-transfected cells within the same field of view were compared. Data are from three independent
experiments, each with ten to 12 cells, and normalized to non-transfected controls.
(I) RAW 264.7 macrophages expressing constitutively active, Rap1V12-RFP. Alexa-647-conjugated oxLDL binding was assessed and quantified as in (E) and (F).
(J) RAW 264.7 macrophages expressing TalinWT-GFP or dominant-negative talin (TalinHD-GFP). DiI oxLDL binding was assessed as in (E). Representative XY
optical slices of CX3CL1-treated macrophages were obtained using spinning-disk confocal microscopy. Scale bar, 10 mm.
(K) Quantification of (D).
Data are from three independent experiments, each with ten to 15 cells, and normalized to control, TalinWT-GFP. Boxplots are as in Figure 1B. *p < 0.05, ***p <
0.0001 were determined by the Kruskal-Wallis test using Dunn’s multiple comparisons test. See also Figure S4.
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Figure 5. Chemokine Signaling Enhances
CD36 Clustering and the Binding of oxLDL
(A) HMDMs were treated with CCL2 or CXCL12
and CD36 clustering was assessed as in Fig-
ure 2C. Data are from three independent experi-
ments, each with eight to ten cells quantified.
(B) HMDMs were treated as in (A), and oxLDL
binding was assessed as in Figure 1C.
Data are from three independent experiments,
eachwith 18–20 cells quantified. ***p < 0.0001was
determined by the Kolmogorov-Smirnov test.macrophage phagocytosis (Boring et al., 1998; Ma et al., 2013).
As illustrated in Figure 5A, both CCL2 and CXCL12 significantly
decreased the fraction of CD36 features corresponding to one
Cy3 fab fragment while concomitantly increasing the fraction of
CD36 features corresponding to two and three or more Cy3
fab fragments. In support of enhanced receptor clustering, we
also found that CCL2 and CXCL12 increased the binding of
oxLDL by 2.27- (IQR = 1.42–3.64) and 2.7-fold (IQR = 1.58–
4.12), respectively (Figure 5B). These data demonstrate that, in
general, chemokine-induced activation of integrins enhances
CD36 clustering and the binding of oxLDL.
Integrins Control the Threshold of Responsiveness
for CD36
To assess more directly the role of integrin signaling in CD36
responsiveness, we developed a model system where the de-
gree of integrin engagement could be tightly controlled. Our
approach entailed lifting HMDMs and re-plating them onto cov-
erslips saturated with 5% BSA, which limits integrin-mediated
adhesion, or coverslips with defined integrin ligands (i.e., fibro-
nectin or collagen). When laid onto BSA, cells exhibited a round
morphology, reflecting impaired cell spreading (Figure 6A).
Further analysis of the resting cytoskeleton structure revealed
that limiting integrin engagement led to the development of
an extremely dense, homogenous actin cortex (Figure 6A). In
contrast, laying cells onto either fibronectin or collagen resulted
in a dynamic actin cortex, with large ruffles and adjacent actin-
depleted zones. Engaging integrins also led to the marked
depletion of cortical F-actin from the dorsal membrane (Fig-
ure 6A). In line with these observations, the dorsal to ventral
F-actin ratio decreased from 1.02 (IQR = 0.75–1.27) on BSA
to 0.61 (IQR = 0.44–0.74) on fibronectin and 0.48 (IQR =
0.37–0.62) on collagen (p < 0.0001 fibronectin or collagen
versus BSA) (Figure 6B). Moreover, the amount of F-actin-
poor zones as a percentage of total surface area increased
drastically from 0.15 (IQR = 0.11–0.25) on BSA to 0.73 (IQR =
0.64–0.79) on fibronectin and 0.55 (IQR = 0.41–0.61) on
collagen (p < 0.0001 fibronectin or collagen versus BSA) (Fig-
ure 6C). The observed results were not due to changes in total
cellular F-actin content but rather reflected a redistribution of
F-actin (Figure 6D). Thus, integrin signaling regulates the state
of the cortical actin cytoskeleton both at the dorsal and ventral
membrane of macrophages.2866 Cell Reports 14, 2859–2871, March 29, 2016 ª2016 The AuthorIf integrin-mediated adhesion regulates the resting cytoskel-
eton, it is conceivable that a feedforward mechanism exists be-
tween the degree of outside-in integrin signaling and CD36
responsiveness. In accordance with this concept, modal anal-
ysis of intensity histograms, as in Figure 2, revealed that CD36
cluster size increased significantly on integrin ligands when
compared to BSA (Figure 6E). Furthermore, single-molecule
tracking experiments demonstrated that CD36 was much less
confined and moved with significantly faster diffusion coeffi-
cients on integrin ligands, accounting for increased receptor
clustering (Figures 6F and 6G). These results suggest that integ-
rin signaling may sensitize CD36 to engage multivalent oxLDL.
This hypothesis was tested by measuring the engagement of
oxLDL in macrophages laid onto BSA, fibronectin, or collagen.
Strikingly, cells on fibronectin or collagen bound 3.2- and 2.1-
fold more oxLDL, respectively, compared to cells on BSA (p <
0.0001 fibronectin versus BSA, p < 0.001 collagen versus BSA)
(Figure 6H). To further verify these results, outside-in integrin
signaling was artificially induced using cross-linking antibodies.
As Figure 6I illustrates, cross-linking b1 or b2 integrins with
monoclonal antibodies followed by Fab2 increased CD36 cluster
size as well as binding of oxLDL by 2.5- and 2.3-fold, respec-
tively (p < 0.0001 versus control) (Figures S5C and S5D; Fig-
ure 6I). Note that caution was taken to block Fc receptors prior
to the addition of integrin antibodies to avoid confounding
signaling. Overall, these data demonstrate that, by controlling
cytoskeletal architecture, integrins set the threshold of respon-
siveness for CD36, thereby regulating the engagement of oxLDL.
Chemokines Accelerate Macrophage Foam Cell
Formation
The results hitherto demonstrate that increased integrin engage-
ment induced by chemokine signaling or by physical cross-link-
ing sensitizes CD36 to engage ligand. Functionally, enhanced
responsiveness toward oxLDL could promote the excessive
accumulation of cholesterol and, thus, the formation of macro-
phage-derived foam cells that drive sterile inflammation.
Macrophages esterify non-essential cholesterol for storage in
specialized organelles called lipid droplets. To assess the effect
of the chemokines on foam cells, lipid droplet formation was as-
sessed using the non-polar probe BODIPY in macrophages
incubated with high concentrations of oxLDL. In keeping with
enhanced ligand engagement, CX3CL1, CCL2, and CXCL12s
Figure 6. Integrins Control the Threshold of Responsiveness for CD36
(A) HMDMs were dropped onto 5% BSA, fibronectin, or collagen-coated substrates for 45 min and stained with phalloidin-488. Representative 3D opacity
reconstructions and corresponding XZ optical slices were obtained using spinning-disk confocal microscopy. Arrows highlight ruffles and asterisks highlight
adjacent, F-actin depleted regions. Scale bars, 10 mm.
(B–D) Quantification of the dorsal to ventral F-actin ratio, F-actin depleted regions, and relative F-actin as in Figures 3D–3F. Data are from three independent
experiments, each with ten to 15 cells. Boxplots are as in Figure 1B. ***p < 0.0001 was determined by the Kolmogorov-Smirnov test.
(E) CD36 clustering analysis in HMDMs laid on different substrates determined as in Figures 2A–2C. Data are from three independent experiments, each with five
to ten cells per condition.
(F and G) Cells were laid onto different substrates (F) as in (A) and (E) and labeled for single-molecule tracking as in Figure 2D. Fraction of CD36 molecules
undergoing confined and free motion and (G) median diffusion coefficients are shown. Data are from three independent experiments, each with eight to ten cells.
Dot plots are as in Figure 2.
(H) Macrophages were laid onto different substrates as in (A), and Alexa-647-conjugated oxLDL binding was assessed and quantified as in Figure 4. ***p <
0.0001,**p < 0.001 were determined by the Kolmogorov-Smirnov test.
(I) Integrins were activated using primary antibody followed by cross-linking Fab2 in HMDMs. Alexa-647-conjugated oxLDL binding was assessed and quantified
as in (H).
*p < 0.05 was determined by the Kolmogorov-Smirnov test. See also Figure S5.each increased lipid droplet formation by 1.54-, 2.28-, and 1.77-
fold, respectively, when compared to controls incubated with
oxLDL alone (p < 0.05, Figures 7A and 7B). Note that in the
absence of oxLDL, the chemokines had little effect on lipid
droplet formation, suggesting that they were not simply altering
macrophage metabolism (Figure 7B). We additionally measured
esterified cholesterol content by biochemical means. As shown
in Figure S5E, in this assay CX3CL1 increased the content of
esterified cholesterol by 2.01-fold compared to controls, con-Cellfirming the reliability of the BODIPY measurements (p < 0.001).
These observations demonstrate that, by promoting engage-
ment of oxLDL, chemokine signaling accelerates macrophage
foam cell formation.
DISCUSSION
Our data demonstrate that by regulating the cortical actin cyto-
skeleton, integrin signaling exerts feedforward control over theReports 14, 2859–2871, March 29, 2016 ª2016 The Authors 2867
Figure 7. Chemokines Enhance Macrophage Foam Cell Formation
(A) BMDMs were incubated with 10% lipoprotein-deficient serum in the presence of CX3CL1, CCL2, or CXCL12, and high concentrations of oxLDL for 24 hr. Lipid
dropletswere labeledwith non-polar BODIPY.Representative extended focus zprojectionswereobtainedusingspinning-disk confocalmicroscopy.Scalebars, 10mm.
(B) Quantification of (A). The integrated BODIPY fluorescence was quantified per cell and normalized to control (–) oxLDL.
Data are from three independent experiments, each withR20 cells. Boxplots are as in Figure 1B. *p < 0.05, ***p < 0.0001 were determined by the Kruskal-Wallis
test using Dunn’s multiple comparisons test.lateral diffusion and clustering of CD36 and, hence, the ability of
macrophages to engage oxLDL. The degree of integrin engage-
ment can be enhanced by chemokines, such as CX3CL1, by
promoting Rap1-mediated, inside-out activation. The resulting
outside-in integrin signaling generates a highly dynamic cortical
actin cytoskeleton, comprising actin-rich ruffles and adjacent
actin-poor zones; the latter facilitates receptor clustering and
serves as the predominant sites of oxLDL engagement. This, in
turn, contributes to the increased accumulation of esterified
cholesterol, accelerating macrophage foam cell formation. To
the best of our knowledge, this is first demonstration that
CD36 activity can be regulated through a mechanism other
than cell-surface expression.
The notion of pre-clustering receptors independent of ligand is
not unique toCD36. This phenomenon has been observed for im-
munoreceptors such as the T cell receptor (TCR), B cell receptor
(BCR), and the high-affinity IgE receptor, FcεRI (Lillemeier et al.,
2010;Mattila et al., 2013;Wilson et al., 2000). In the case of T lym-
phocytes, enhanced pre-clustering of the TCR inmemory versus
naive cells was reported to increase sensitivity to multivalent an-
tigen by 100- to 3,000-fold. This effect is attributed in part to
increased avidity for antigen arising from the increased multiva-
lency of TCR oligomers (Kumar et al., 2011). A similar model
hasbeenproposed for theBCR (Fiala et al., 2013). In viewof these
studies and our own data, we propose that increased pre-clus-
tering of CD36 in response to chemokines enhances its avidity
for oxLDL. In addition, the enhanced clustering of CD36 may in-
crease the rateof ligand rebinding and therefore reduce theeffec-
tive dissociation constant of oxLDL. This concept is supported by
studies utilizing computational modeling to investigate receptor-
ligand interaction kinetics (Gopalakrishnan et al., 2005). Impor-
tantly, the effect of pre-clustering on ligand engagement will be
highly dependent on the cell-surface density of the receptor,2868 Cell Reports 14, 2859–2871, March 29, 2016 ª2016 The Authorthe rate at which clusters assemble and disassemble, as well
as the concentration and multivalency of the ligand itself. It re-
mains to bedeterminedwhetherCD36clusters are formedby ho-
motypic interactions, as is the case for the TCR, or interactions
with ancillary scaffolding molecules.
In our experimental setup, integrins bind substratum exclu-
sively on the ventral cell surface and receptors bind oxLDL
primarily on the dorsal cell surface. It is noteworthy that, in this
system, integrin-mediated adhesion affects the cortical actin ar-
chitecture not only at the ventral surface, but also at the dorsal
surface. This effect is similar to what has been reported by Jau-
mouille´ et al. (2014) and further demonstrates that integrin
signaling controls both local and distal actin polymerization.
While an informative model, the same scenario is unlikely to exist
within the tissue microenvironment in vivo. Rather, extracellular
matrix (ECM) will surround the cells in three-dimensional space,
and a clear distinction between the dorsal and ventral membrane
may not exist. The ECM, however, can be both compositionally
and topographically heterogeneous in anygiven tissue and there-
fore integrins will not be engaged uniformly (Kubow and Horwitz,
2011). As a result, regionsof the cortical cytoskeletonwill byhigh-
ly dynamic, similar to our in vitro system, creating ‘‘hot spots’’ of
clusteredCD36distal to the sites of integrin engagement. The net
effect of this response would be increased binding of oxLDL to
spatially coordinated regions of the plasma membrane.
Apart fromchemokines andother cytokines that activate integ-
rins, the intrinsic mechanical properties of the ECM itself will also
influence how prepared a macrophage is to engage oxLDL.
These factors will dictate the degree of integrin activation, the
type of integrin activated, and the resulting actin cytoskeletal ar-
chitecture of a cell (Humphrey et al., 2014). It is important to note
that the composition of the ECM is drastically altered as athero-
sclerotic lesions progress. The evolving ECM results from ans
ever-changing cytokine milieu that drives vascular fibrosis, the
deposition of transitional ECM components (i.e., fibronectin
and fibrinogen), and the release of matrix-degrading enzymes
(Akyildiz et al., 2014). Therefore, as atherogenesis proceeds,
the ECM may be altered to a state that ‘‘over-primes’’ receptors
to engage oxLDL. This notion is supported by our observations
demonstrating that macrophages plated on integrin ligands
have a higher degree of CD36 clustering, and a higher degree
of oxLDL engagement compared to cells on substrates that limit
integrin activation (Figure 6). Compositional changes will, in turn,
affect themechanical properties of theECMsuchas rigidity, elas-
ticity, as well as compressive and tensile strength, altering the
amount of force exerted on individual macrophages (DuFort
et al., 2011). These changes in forces are sensed and transduced
primarily by integrins, which form a critical link between the ECM
and the cytoskeleton. Thus, cells will respond to changes in me-
chanical force by adjusting their actin cytoskeletal architecture,
thereby impacting CD36 clustering.
Our work highlights an unappreciated consequence of dysre-
gulated chemokine production during atherogenesis: the con-
tinued priming of integrins by multiple chemokines will drive
excessive engagement and internalization of oxLDL. During
vascular inflammation, chemokines are traditionally thought to
promote the recruitment of leukocytes to the vascular wall. How-
ever, it is becoming increasingly apparent that they can addition-
ally impact immune function directly (Zernecke and Weber,
2010). The priming of receptors for engagement of oxLDL can
now be included in the list of effects elicited by the chemokines.
Thus, it is conceivable that a detrimental feedback loop results
following initial macrophage recruitment to the intima; cells
over-activate integrins in response to dysregulated chemokine
production and thereby excessively prime receptors. As a result,
the macrophages accumulate oxLDL, transform into foam cells,
undergo necrosis, and subsequently release pro-inflammatory
stimuli that exacerbate production of more chemokines. During
atherogenesis in vivo, it is likely that multiple chemokines exert
synergistic effects and that their collective inputs dictate the inte-
gratedmacrophage response (e.g.,CD36clustering) and thepro-
gression of atherosclerosis. Two lines of evidence support this
notion: (1) three structurally distinct chemokines that we tested
each enhanced CD36 clustering, the engagement of oxLDL,
and the accumulation of esterified cholesterol and (2) triple dele-
tion of CX3CR1, CCR5, and CCL2 in ApoE
/mice yields an ad-
ditive reduction in atherosclerosis (Combadie`re et al., 2008).
Overall, our data suggest that receptor clusteringmay serve as
a tunable variable, controlled by the integration of cytokine in-
puts that converge on integrin signaling, and ultimately influence
the progression of inflammation.EXPERIMENTAL PROCEDURES
OxLDL Binding and Internalization
OxLDL internalization was assessed inmacrophages incubated with DiI oxLDL
for 25 min at 37 in the presence or absence of CX3CL1 (100 ng/ml), followed
by washing with PBS. Prior to fixation, non-internalized oxLDL was removed
by a 1-min incubation with trypsin. For binding assays, macrophages were
pre-treated with CX3CL1 (100 ng/ml) for 5 min at 37
C. OxLDL binding was
assessed by incubating cells with either DiI oxLDL (2 mg/ml) or Alexa-647-con-
jugated oxLDL (2 mg/ml) for 1 min at 37, followed by washing with PBS andCellfixation. OxLDL fluorescence per cell was measured using ImageJ software
as described in Image Processing and Analysis (see Supplemental Experi-
mental Procedures). All animal experiments were approved by The Hospital
for Sick Children Institutional Animal Care and Use Committee, and adhered
to the NIH Guide for the Care and Use of Laboratory Animals.
Single-Molecule Imaging and Diffusion Analysis
Cells were initially blockedwith 5%donkey serum for 5min and incubated with
anti-CD36 Fab fragment (clone 131.1) diluted in HEPES-buffered RPMI-1640
(HPMI). Following washing, cells were incubated with biotin-conjugated sec-
ondary Fab fragment (0.375 mg/ml) diluted in HPMI for 10 min. In the latter
case, cells were washed further then incubated with Qdot 655-conjugated-
streptavidin (0.1 nM) diluted in biotin-free HBSS for 4 min. Unengaged strep-
tavidin was blocked by brief incubation with HPMI containing 0.2 mg/ml biotin,
followed by washing. All labeling steps and washes were performed at 10C to
minimize receptor cross-linking. Coverslips were transferred to Leiden cham-
bers, incubated in HPMI, and warmed to 37C for live imaging.
For CD36 clustering analysis, cells were fixed in 4%paraformaldehyde (PFA)
for 20 min, and labeling was performed as described above using anti-CD36
Fab fragment and secondary anti-mouse Cy3-conjugated Fab fragment
(0.750 mg/ml). Cells were post-fixed using 3% PFA supplemented with 0.1%
gluteraldehyde for 10 min. For each fixation step, excess aldehydes were
neutralized with 100 mM glycine.
Single-molecule tracking was performed using a Carl Zeiss Axiovert 200 M
inverted epifluorescence microscope equipped with a heated stage, a custom
2.53 magnifying lens, a 1003 (numerical aperture [NA] 1.45) oil-immersion
objective, an Exfo X-Cite 120 light source, and a Hamamatsu C9100-13
back-thinned, electron-multiplying charge-coupled device (EM-CCD) camera.
Images were acquired on the dorsal cell surface at a frame rate of 33 Hz for
Qdots using Volocity software (PerkinElmer).
Single molecules were detected and tracked as described previously for
CD36 (Jaqaman et al., 2008, 2011). Motion classifications and diffusion coef-
ficients were determined using a moment scaling spectrum (MSS) analysis
(Ewers et al., 2005; Ferrari et al., 2001; Jaqaman et al., 2011). Confinement di-
mensions were derived by eigenvalue decomposition of the variance-covari-
ance matrix of particle positions (Jaqaman et al., 2011).
In some instances, adherent macrophages were lifted into suspension using
10 mM EDTA and dropped onto coverslips coated with 5% BSA, fibronectin
(50 mg/ml) or collagen IV (50 mg/ml) for 30 min. Cells were then labeled for sin-
gle-molecule tracking and imaged as described above.
Spinning-Disk Confocal Microscopy
The spinning-disk confocal system (Quorum Technologies) consisted of an
Axiovert 200 M microscope (Carl Zeiss) equipped with a 633 (NA 1.4) oil im-
mersion objective as well an additional 1.53magnifying lens. This microscope
was equipped with diode-pumped solid-state lasers (440, 491, 561, 638, and
655 nm; Spectral Applied Research) and amotorized XY stage (Applied Scien-
tific Instrumentation). Images were acquired using a back-thinned, EM-CCD
camera (model C9100-13 ImagEM; Hamamatsu Photonics) controlled using
Volocity software, v.6.0.1 (PerkinElmer).
Structured Illumination Microscopy
Fixed samples were mounted using Prolong Diamond Antifade Mountant (Life
Technologies). Images were acquired using the Carl Zeiss ELYRA PS1 system
equipped with an Axio Observer Z1 microscope, a 633 (1.4 NA) apochromat
oil immersion objective, a 1.63 optovar, and an Andor iXon3 885 EM-CCD
camera. Three orientation angles of the excitation grid with five phases
each were acquired for each z plane. Images were reconstructed using the
structured illumination module included with the ZEN software package
(Carl Zeiss).
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